Interstitial 22q13 deletions not involving SHANK3 gene

A new contiguous gene syndrome

Vittoria Disciglio, Caterina Lo Rizzo, Maria Antonietta Mencarelli, Mafalda Mucciolo, Annabella Marozza, Chiara Di Marco, Antonio Massarelli, Valentina Canocchi, Margherita Baldassarri, Enea Ndoni, Elisa Frullanti, Sonia Amabile, Britt Marie Anderlid, Kay Metcalfe, Cédric Le Caignec, Albert David, Alan Fryer, Odile Boute, Andrieux Joris, Donatella Greco & 7 others Vanna Pecile, Roberta Battini, Antonio Novelli, Marco Fichera, Corrado Romano, Francesca Mari, Alessandra Renieri

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Phelan-McDermid syndrome (22q13.3 deletion syndrome) is a contiguous gene disorder resulting from the deletion of the distal long arm of chromosome 22. SHANK3, a gene within the minimal critical region, is a candidate gene for the major neurological features of this syndrome. We report clinical and molecular data from a study of nine patients with overlapping interstitial deletions in 22q13 not involving SHANK3. All of these deletions overlap with the largest, but not with the smallest deletion associated with Phelan-McDermid syndrome. The deletion sizes and breakpoints varied considerably among our patients, with the largest deletion spanning 6.9Mb and the smallest deletion spanning 2.7Mb. Eight out of nine patients had a de novo deletion, while in one patient the origin of deletion was unknown. These patients shared clinical features common to Phelan-McDermid syndrome: developmental delay (11/12), speech delay (11/12), hypotonia (9/12), and feeding difficulties (7/12). Moreover, the majority of patients (8/12) exhibited macrocephaly. In the minimal deleted region, we identified two candidate genes, SULT4A1 and PARVB (associated with the PTEN pathway), which could be associated in our cohort with neurological features and macrocephaly/hypotonia, respectively. This study suggests that the haploinsufficiency of genes in the 22q13 region beside SHANK3 contributes to cognitive and speech development, and that these genes are involved in the phenotype associated with the larger Phelan-McDermid syndrome 22q13 deletions. Moreover, because the deletions in our patients do not involve the SHANK3 gene, we posit the existence of a new contiguous gene syndrome proximal to the smallest terminal deletions in the 22q13 region.

Original languageEnglish
Pages (from-to)1666-1676
Number of pages11
JournalAmerican Journal of Medical Genetics, Part A
Volume164
Issue number7
DOIs
Publication statusPublished - 2014

Fingerprint

Genes
Megalencephaly
Muscle Hypotonia
Language Development Disorders
Haploinsufficiency
Chromosomes, Human, Pair 22
Telomeric 22q13 Monosomy Syndrome
Phenotype

Keywords

  • 22q13.3 deletion
  • PARVB
  • Phelan-McDermid syndrome
  • SHANK3
  • SULT4A1

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics
  • Medicine(all)

Cite this

Disciglio, V., Rizzo, C. L., Mencarelli, M. A., Mucciolo, M., Marozza, A., Di Marco, C., ... Renieri, A. (2014). Interstitial 22q13 deletions not involving SHANK3 gene: A new contiguous gene syndrome. American Journal of Medical Genetics, Part A, 164(7), 1666-1676. https://doi.org/10.1002/ajmg.a.36513

Interstitial 22q13 deletions not involving SHANK3 gene : A new contiguous gene syndrome. / Disciglio, Vittoria; Rizzo, Caterina Lo; Mencarelli, Maria Antonietta; Mucciolo, Mafalda; Marozza, Annabella; Di Marco, Chiara; Massarelli, Antonio; Canocchi, Valentina; Baldassarri, Margherita; Ndoni, Enea; Frullanti, Elisa; Amabile, Sonia; Anderlid, Britt Marie; Metcalfe, Kay; Le Caignec, Cédric; David, Albert; Fryer, Alan; Boute, Odile; Joris, Andrieux; Greco, Donatella; Pecile, Vanna; Battini, Roberta; Novelli, Antonio; Fichera, Marco; Romano, Corrado; Mari, Francesca; Renieri, Alessandra.

In: American Journal of Medical Genetics, Part A, Vol. 164, No. 7, 2014, p. 1666-1676.

Research output: Contribution to journalArticle

Disciglio, V, Rizzo, CL, Mencarelli, MA, Mucciolo, M, Marozza, A, Di Marco, C, Massarelli, A, Canocchi, V, Baldassarri, M, Ndoni, E, Frullanti, E, Amabile, S, Anderlid, BM, Metcalfe, K, Le Caignec, C, David, A, Fryer, A, Boute, O, Joris, A, Greco, D, Pecile, V, Battini, R, Novelli, A, Fichera, M, Romano, C, Mari, F & Renieri, A 2014, 'Interstitial 22q13 deletions not involving SHANK3 gene: A new contiguous gene syndrome', American Journal of Medical Genetics, Part A, vol. 164, no. 7, pp. 1666-1676. https://doi.org/10.1002/ajmg.a.36513
Disciglio, Vittoria ; Rizzo, Caterina Lo ; Mencarelli, Maria Antonietta ; Mucciolo, Mafalda ; Marozza, Annabella ; Di Marco, Chiara ; Massarelli, Antonio ; Canocchi, Valentina ; Baldassarri, Margherita ; Ndoni, Enea ; Frullanti, Elisa ; Amabile, Sonia ; Anderlid, Britt Marie ; Metcalfe, Kay ; Le Caignec, Cédric ; David, Albert ; Fryer, Alan ; Boute, Odile ; Joris, Andrieux ; Greco, Donatella ; Pecile, Vanna ; Battini, Roberta ; Novelli, Antonio ; Fichera, Marco ; Romano, Corrado ; Mari, Francesca ; Renieri, Alessandra. / Interstitial 22q13 deletions not involving SHANK3 gene : A new contiguous gene syndrome. In: American Journal of Medical Genetics, Part A. 2014 ; Vol. 164, No. 7. pp. 1666-1676.
@article{29396cb031984229a9370aa20733bd53,
title = "Interstitial 22q13 deletions not involving SHANK3 gene: A new contiguous gene syndrome",
abstract = "Phelan-McDermid syndrome (22q13.3 deletion syndrome) is a contiguous gene disorder resulting from the deletion of the distal long arm of chromosome 22. SHANK3, a gene within the minimal critical region, is a candidate gene for the major neurological features of this syndrome. We report clinical and molecular data from a study of nine patients with overlapping interstitial deletions in 22q13 not involving SHANK3. All of these deletions overlap with the largest, but not with the smallest deletion associated with Phelan-McDermid syndrome. The deletion sizes and breakpoints varied considerably among our patients, with the largest deletion spanning 6.9Mb and the smallest deletion spanning 2.7Mb. Eight out of nine patients had a de novo deletion, while in one patient the origin of deletion was unknown. These patients shared clinical features common to Phelan-McDermid syndrome: developmental delay (11/12), speech delay (11/12), hypotonia (9/12), and feeding difficulties (7/12). Moreover, the majority of patients (8/12) exhibited macrocephaly. In the minimal deleted region, we identified two candidate genes, SULT4A1 and PARVB (associated with the PTEN pathway), which could be associated in our cohort with neurological features and macrocephaly/hypotonia, respectively. This study suggests that the haploinsufficiency of genes in the 22q13 region beside SHANK3 contributes to cognitive and speech development, and that these genes are involved in the phenotype associated with the larger Phelan-McDermid syndrome 22q13 deletions. Moreover, because the deletions in our patients do not involve the SHANK3 gene, we posit the existence of a new contiguous gene syndrome proximal to the smallest terminal deletions in the 22q13 region.",
keywords = "22q13.3 deletion, PARVB, Phelan-McDermid syndrome, SHANK3, SULT4A1",
author = "Vittoria Disciglio and Rizzo, {Caterina Lo} and Mencarelli, {Maria Antonietta} and Mafalda Mucciolo and Annabella Marozza and {Di Marco}, Chiara and Antonio Massarelli and Valentina Canocchi and Margherita Baldassarri and Enea Ndoni and Elisa Frullanti and Sonia Amabile and Anderlid, {Britt Marie} and Kay Metcalfe and {Le Caignec}, C{\'e}dric and Albert David and Alan Fryer and Odile Boute and Andrieux Joris and Donatella Greco and Vanna Pecile and Roberta Battini and Antonio Novelli and Marco Fichera and Corrado Romano and Francesca Mari and Alessandra Renieri",
year = "2014",
doi = "10.1002/ajmg.a.36513",
language = "English",
volume = "164",
pages = "1666--1676",
journal = "American Journal of Medical Genetics, Part A",
issn = "1552-4825",
publisher = "Wiley-Liss Inc.",
number = "7",

}

TY - JOUR

T1 - Interstitial 22q13 deletions not involving SHANK3 gene

T2 - A new contiguous gene syndrome

AU - Disciglio, Vittoria

AU - Rizzo, Caterina Lo

AU - Mencarelli, Maria Antonietta

AU - Mucciolo, Mafalda

AU - Marozza, Annabella

AU - Di Marco, Chiara

AU - Massarelli, Antonio

AU - Canocchi, Valentina

AU - Baldassarri, Margherita

AU - Ndoni, Enea

AU - Frullanti, Elisa

AU - Amabile, Sonia

AU - Anderlid, Britt Marie

AU - Metcalfe, Kay

AU - Le Caignec, Cédric

AU - David, Albert

AU - Fryer, Alan

AU - Boute, Odile

AU - Joris, Andrieux

AU - Greco, Donatella

AU - Pecile, Vanna

AU - Battini, Roberta

AU - Novelli, Antonio

AU - Fichera, Marco

AU - Romano, Corrado

AU - Mari, Francesca

AU - Renieri, Alessandra

PY - 2014

Y1 - 2014

N2 - Phelan-McDermid syndrome (22q13.3 deletion syndrome) is a contiguous gene disorder resulting from the deletion of the distal long arm of chromosome 22. SHANK3, a gene within the minimal critical region, is a candidate gene for the major neurological features of this syndrome. We report clinical and molecular data from a study of nine patients with overlapping interstitial deletions in 22q13 not involving SHANK3. All of these deletions overlap with the largest, but not with the smallest deletion associated with Phelan-McDermid syndrome. The deletion sizes and breakpoints varied considerably among our patients, with the largest deletion spanning 6.9Mb and the smallest deletion spanning 2.7Mb. Eight out of nine patients had a de novo deletion, while in one patient the origin of deletion was unknown. These patients shared clinical features common to Phelan-McDermid syndrome: developmental delay (11/12), speech delay (11/12), hypotonia (9/12), and feeding difficulties (7/12). Moreover, the majority of patients (8/12) exhibited macrocephaly. In the minimal deleted region, we identified two candidate genes, SULT4A1 and PARVB (associated with the PTEN pathway), which could be associated in our cohort with neurological features and macrocephaly/hypotonia, respectively. This study suggests that the haploinsufficiency of genes in the 22q13 region beside SHANK3 contributes to cognitive and speech development, and that these genes are involved in the phenotype associated with the larger Phelan-McDermid syndrome 22q13 deletions. Moreover, because the deletions in our patients do not involve the SHANK3 gene, we posit the existence of a new contiguous gene syndrome proximal to the smallest terminal deletions in the 22q13 region.

AB - Phelan-McDermid syndrome (22q13.3 deletion syndrome) is a contiguous gene disorder resulting from the deletion of the distal long arm of chromosome 22. SHANK3, a gene within the minimal critical region, is a candidate gene for the major neurological features of this syndrome. We report clinical and molecular data from a study of nine patients with overlapping interstitial deletions in 22q13 not involving SHANK3. All of these deletions overlap with the largest, but not with the smallest deletion associated with Phelan-McDermid syndrome. The deletion sizes and breakpoints varied considerably among our patients, with the largest deletion spanning 6.9Mb and the smallest deletion spanning 2.7Mb. Eight out of nine patients had a de novo deletion, while in one patient the origin of deletion was unknown. These patients shared clinical features common to Phelan-McDermid syndrome: developmental delay (11/12), speech delay (11/12), hypotonia (9/12), and feeding difficulties (7/12). Moreover, the majority of patients (8/12) exhibited macrocephaly. In the minimal deleted region, we identified two candidate genes, SULT4A1 and PARVB (associated with the PTEN pathway), which could be associated in our cohort with neurological features and macrocephaly/hypotonia, respectively. This study suggests that the haploinsufficiency of genes in the 22q13 region beside SHANK3 contributes to cognitive and speech development, and that these genes are involved in the phenotype associated with the larger Phelan-McDermid syndrome 22q13 deletions. Moreover, because the deletions in our patients do not involve the SHANK3 gene, we posit the existence of a new contiguous gene syndrome proximal to the smallest terminal deletions in the 22q13 region.

KW - 22q13.3 deletion

KW - PARVB

KW - Phelan-McDermid syndrome

KW - SHANK3

KW - SULT4A1

UR - http://www.scopus.com/inward/record.url?scp=84902546649&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902546649&partnerID=8YFLogxK

U2 - 10.1002/ajmg.a.36513

DO - 10.1002/ajmg.a.36513

M3 - Article

VL - 164

SP - 1666

EP - 1676

JO - American Journal of Medical Genetics, Part A

JF - American Journal of Medical Genetics, Part A

SN - 1552-4825

IS - 7

ER -